INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE Russian patent published in 2012 - IPC A61K31/453 A61P35/00

Abstract RU 2445093 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: what is offered is using 40-O-(2-hydroxyethyl)rapamycin for preparing a pharmaceutical composition for treating a renal tumour representing carcinoma.

EFFECT: 40-O-(2-hydroxyethyl)rapamycin twice reduces tumour growth time or death rate of the patients with advanced renal cell carcinoma.

1 tbl

Similar patents RU2445093C2

Title	Year	Author	Number
USE OF RAPAMYCIN DERIVATIVE	2011	Lane Khejdi O`Rejlli Terens Vud Dzhinetta Mardzhori	RU2483727C1
APPLICATION OF RAPAMYCIN DERIVATIVE	2013	Khejdi Lane Terens O'Rejlli Dzhinetta Mardzhori Vud	RU2659725C2
APPLICATION OF RAPAMYCIN DERIVATIVE	2013	Khejdi Lane Terens O'Rejlli Dzhinetta Mardzhori Vud	RU2665138C2
COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER	2002	Lane Khejdi O`Rejlli Terens Vud Dzhinetta Mardzhori	RU2322981C2
CANCER MEDICAL TREATMENT	2005	Lane Khejdi O`Rejlli Terens Vud Dzhinetta Mardzhori	RU2325906C2
RAPAMYCIN DERIVATIVE OR IMPDH INHIBITOR FOR TREATING POLYCYSTIC KIDNEY DISEASE	2006	Fehrber Lotar Gshajdmajer Kharal'D	RU2491933C2
BIOMARKERS	2005	Bevink Ivan Bulaj Anne Lane Khajdi O'Rejlli Terens Tomas Dzhordzh	RU2429297C2
BIOMARKER	2005	Bevink Ivan Bulaj Anne Lane Khajdi O'Rejlli Terens Tomas Dzhordzh	RU2385944C2
NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT	2013	Disej Nejl P. Soon-Shiong Patrik Trieu Vuong	RU2678448C2
NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT	2008	Disehj Nejl P. Soon-Shiong Patrik Trieu Vuong	RU2483714C2

RU 2 445 093 C2

Authors

Lane Khejdi

O'Rejlli Terens

Vud Dzhinetta Mardzhori

Dates

2012-03-20—Published

2006-11-16—Filed